
The objectives of this post-hoc analysis were to examine the safety and efficacy of omadacycline by BMI categories and diabetes history in adults with acute bacterial skin and skin structure infections (ABSSSI) from two pivotal Phase III studies patients were randomized 1:1 to IV omadacycline or linezolid for 7–14 days, with optional transition to oral medication...
Like
Save
Share